| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.41 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.38 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |